These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 8525252)

  • 1. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
    Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mesalazine].
    Engelhardt K; Mohr K
    Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
    [No Abstract]   [Full Text] [Related]  

  • 4. Pleuropericarditis related to the use of mesalamine.
    Gujral N; Friedenberg F; Friedenberg J; Gabriel G; Kotler M; Levine G
    Dig Dis Sci; 1996 Mar; 41(3):624-6. PubMed ID: 8617147
    [No Abstract]   [Full Text] [Related]  

  • 5. Folliculitis and mesalamine.
    Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
    Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pericarditis during inflammatory bowel diseases. Extra-intestinal or iatrogenic complication?].
    Heresbach D; Rabot A; Génetet N; Marteau P; Stéphan C; Bretagne JF; Gosselin M
    Gastroenterol Clin Biol; 1994; 18(8-9):782-5. PubMed ID: 7875451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mesalazine-induced acute pericarditis].
    Sierra Ausín M; Rascarachi G; Díez Rodríguez R; Arias Rodríguez L; Del Pozo Maroto E; Muñoz Núñez F
    Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesalamine-induced lung toxicity.
    Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
    Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
    Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
    Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
    Niv Y
    Isr J Med Sci; 1987 Nov; 23(11):1161-3. PubMed ID: 3436802
    [No Abstract]   [Full Text] [Related]  

  • 11. [False melanuria in a female patient treated with 5-ASA for ulcerative colitis].
    Cuende JI; Gómez MT; García M; Pérez IJ
    Med Clin (Barc); 1995 May; 104(20):798. PubMed ID: 7783478
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.
    Perrot S; Aslangul E; Szwebel T; Gadhoum H; Romnicianu S; Le Jeunne C
    Int J Colorectal Dis; 2007 Sep; 22(9):1119-21. PubMed ID: 17440739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ; Mayer L; Abreu MT
    J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myopericarditis in a patient with ulcerative colitis treated with mesalazine].
    Martín M; Santamarta E; de la Iglesia JM; Saiz A
    Med Clin (Barc); 2010 Jan; 134(1):43-4. PubMed ID: 19423137
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
    Fornaciari G; Maccari S; Borgatti PP; Rustichelli R; Amelio N; Lattuada I; Plancher AC
    J Clin Gastroenterol; 1997 Jan; 24(1):37-9. PubMed ID: 9013349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and recurrence prevention ulcerative colitis].
    Schölmerich J
    Internist (Berl); 1995 Dec; 36(12):1124-32. PubMed ID: 8567217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.